Humasis Co. Ltd. (KOSDAQ: 205470)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,625.00
-65.00 (-3.85%)
Dec 20, 2024, 9:00 AM KST
-20.92%
Market Cap 183.87B
Revenue (ttm) 16.57B
Net Income (ttm) -28.05B
Shares Out 113.15M
EPS (ttm) -231.92
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,397,445
Open 1,696.00
Previous Close 1,690.00
Day's Range 1,625.00 - 1,707.00
52-Week Range 1,489.00 - 3,235.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 7, 2025

About Humasis

Humasis Co. Ltd. manufactures and sells pharmaceuticals and medical devices in South Korea and internationally. It offers immunodiagnostic kits, such as quantitative and qualitative tests, cardiac and cancer markers, infectious diseases, hormones, and women’s health. The company also provides bio-material products, such as COVID-19 nucleocapsid protein, human immunodeficiency virus surface proteins, COVID-19 RT-PCR kit, and COVID-19 Variant RT-qPCR kit, as well as MPXV real time PCR kit, a real-time polymerase chain reaction assay for the quali... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2000
Employees 71
Stock Exchange KOSDAQ
Ticker Symbol 205470
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.